North Carolina
CNS trials open to children and teens in North Carolina
14 CNS studies open to children and teens are recruiting participants at sites in 7 cities across North Carolina as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every North Carolina city with a recruiting study
By research area: Migraine (5), ADHD (3), Depression (3), Epilepsy (2), Schizophrenia (1).
Durham (5), Chapel Hill (3), Charlotte (3), Greensboro (1), Kinston (1), Statesville (1), Winston-Salem (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
ADHD: recently updated in North Carolina
Basic details from each study's public record (the 12 most recently updated of 14). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Durham
- Registry record
- NCT04781140 · updated
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Observational
- Ages 0 to 20
- All sexes
- Sponsor
- Duke University
- Recruiting in
- Durham
- Registry record
- NCT04278404 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in North Carolina on ClinicalTrials.gov.
Depression: recently updated in North Carolina
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Recruiting in
- Chapel Hill
- Registry record
- NCT07048574 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Chapel Hill
- Registry record
- NCT07227454 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in North Carolina on ClinicalTrials.gov.
Epilepsy: recently updated in North Carolina
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Recruiting in
- Durham
- Registry record
- NCT07531745 · updated
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Recruiting in
- Durham
- Registry record
- NCT05419492 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in North Carolina on ClinicalTrials.gov.
Migraine: recently updated in North Carolina
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Charlotte
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Charlotte
- Registry record
- NCT04743141 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Greensboro
- Registry record
- NCT05711394 · updated
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Phase 1
- Ages 6 to 11
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Statesville · Winston-Salem
- Registry record
- NCT06995729 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Charlotte
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in North Carolina on ClinicalTrials.gov.
Schizophrenia: recently updated in North Carolina
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Recruiting in
- Kinston
- Registry record
- NCT05648591 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in North Carolina on ClinicalTrials.gov.
Ask about studies in North Carolina
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections